Literature DB >> 14736422

Bivalent antibody phage display mimics natural immunoglobulin.

Chingwei V Lee1, Sachdev S Sidhu, Germaine Fuh.   

Abstract

We report the development of a system for displaying bivalent antibody fragments on M13 bacteriophage in a manner that effectively mimics the binding behavior of natural antibodies. In the "bivalent display" format, two copies of antigen binding sites are displayed on the coat of a single phage particle. Bivalent display was first achieved by the insertion of a dimerization domain, consisting of an IgG1 hinge region and a homodimerizing GCN4 leucine zipper, between a Fab and the C-terminal domain of the M13 gene-3 minor coat protein. In a phagemid-based display system, the resulting "Fab'-zip-phage" particles display bivalent Fabs that resemble natural IgGs. An important functional consequence of bivalent display is an avidity effect, which results in a greatly reduced off-rate for phage bound to immobilized antigen. The avidity effect improved the capture and retention of bivalent Fab'-zip-phage relative to monovalent Fab-phage both with antigen immobilized on plates and with cell surface antigen. To examine the requirements for bivalent display on phage, we systematically trimmed down the dimerization domain and found that a single cysteine was sufficient to confer the same avidity effect conferred by the complete dimerization domain. Bivalent antibody phage display should be useful for many applications. In particular, the technology should aid in the production of antibodies against difficult antigens, and also, in selections that require dimerization for activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736422     DOI: 10.1016/j.jim.2003.11.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  29 in total

1.  Development of a novel mammalian cell surface antibody display platform.

Authors:  Chen Zhou; Frederick W Jacobsen; Ling Cai; Qing Chen; Weyen David Shen
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

2.  Oligovalent Fab display on M13 phage improved by directed evolution.

Authors:  Tuomas Huovinen; Hanna Sanmark; Jani Ylä-Pelto; Markus Vehniäinen; Urpo Lamminmäki
Journal:  Mol Biotechnol       Date:  2010-03       Impact factor: 2.695

3.  Improvement of the crystallizability and expression of an RNA crystallization chaperone.

Authors:  Priyadarshini P Ravindran; Annie Héroux; Jing-Dong Ye
Journal:  J Biochem       Date:  2011-07-23       Impact factor: 3.387

4.  Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration.

Authors:  Patrick Koenig; Chingwei V Lee; Sarah Sanowar; Ping Wu; Jeremy Stinson; Seth F Harris; Germaine Fuh
Journal:  J Biol Chem       Date:  2015-06-18       Impact factor: 5.157

5.  Protein and Antibody Engineering by Phage Display.

Authors:  J C Frei; J R Lai
Journal:  Methods Enzymol       Date:  2016-06-29       Impact factor: 1.600

6.  The scope of phage display for membrane proteins.

Authors:  Rosemarie Vithayathil; Richard M Hooy; Melanie J Cocco; Gregory A Weiss
Journal:  J Mol Biol       Date:  2011-10-20       Impact factor: 5.469

7.  A two-in-one antibody engineered from a humanized interleukin 4 antibody through mutation in heavy chain complementarity-determining regions.

Authors:  Chingwei V Lee; Patrick Koenig; Germaine Fuh
Journal:  MAbs       Date:  2014-03-11       Impact factor: 5.857

8.  Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists.

Authors:  Yingnan Zhang; Mark Ultsch; Nicholas J Skelton; Daniel J Burdick; Maureen H Beresini; Wei Li; Monica Kong-Beltran; Andrew Peterson; John Quinn; Cecilia Chiu; Yan Wu; Steven Shia; Paul Moran; Paola Di Lello; Charles Eigenbrot; Daniel Kirchhofer
Journal:  Nat Struct Mol Biol       Date:  2017-08-21       Impact factor: 15.369

9.  Characterization of engineered actin binding proteins that control filament assembly and structure.

Authors:  Crista M Brawley; Serdar Uysal; Anthony A Kossiakoff; Ronald S Rock
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

10.  CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.

Authors:  Helena Persson; Wei Ye; Amy Wernimont; Jarrett J Adams; Akiko Koide; Shohei Koide; Robert Lam; Sachdev S Sidhu
Journal:  J Mol Biol       Date:  2012-12-03       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.